Quadrant Capital Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,301
Closed -$66.4K 2860
2024
Q4
$66.4K Buy
1,301
+143
+12% +$7.03K ﹤0.01% 1263
2024
Q3
$47.8K Sell
1,158
-239
-17% -$11.5K ﹤0.01% 1479
2024
Q2
$67.3K Buy
1,397
+1,357
+3,393% +$60.1K 0.01% 1244
2024
Q1
$1.92K Sell
40
-2
-5% -$107 ﹤0.01% 2521
2023
Q4
$2.73K Sell
42
-313
-88% -$18.8K ﹤0.01% 2411
2023
Q3
$23.2K Buy
355
+314
+766% +$19.8K ﹤0.01% 1641
2023
Q2
$2.38K Sell
41
-169
-80% -$10.7K ﹤0.01% 2377
2023
Q1
$13K Buy
210
+143
+213% +$8.58K ﹤0.01% 1907
2022
Q4
$4.26K Sell
67
-124
-65% -$8.99K ﹤0.01% 2238
2022
Q3
$14K Buy
191
+12
+7% +$893 ﹤0.01% 1745
2022
Q2
$12K Buy
+179
New +$12.9K ﹤0.01% 1581

Other funds holding NARI

Quadrant Capital Group's NARI Position: Q1 2025 in Review

Quadrant Capital Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 1,301 shares — an estimated $66.4K sold.

Quadrant Capital Group first reported a position in NARI in Q2 2022 and held it in 11 quarters. The position peaked at $67.3K in Q2 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Quadrant Capital Group reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Quadrant Capital Group sold 1,301 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $66.4K.
  • Quadrant Capital Group first reported a position in Inari Medical, Inc. Common Stock in Q2 2022 and held it in 11 quarters.
  • Quadrant Capital Group's Inari Medical, Inc. Common Stock position peaked at $67.3K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Quadrant Capital Group's 13F filing for Q1 2025, filed 13 May 2025.